The panel agreed on the pathophysiological relevance of rapid passage of nutrients to the small bowel, on the role of decreased gastric volume capacity and release of glucagon-like peptide 1
The maximum treatment period in our study was 2 years, and its expected that these drugs will be used for much longer in real-world settings, especially considering the high likeliness of weight regain once you discontinue treatment. She underlined the significant public health concern that is obesity, with prevalence rates continuing to rise globally. For a while, we were limited to lifestyle interventions, diet and exercise, which have been shown time and time again to not be sufficient for sustained weight loss in this patient population, she said
Journal of Pharmaceutical Sciences, 112(5), 2189-2204.
What Happens When You Stop Taking GLP-1 Medications
In this study, disproportionality was evaluated by the empirical Bayes geometric mean (EBGM) from multi-item gamma Poisson shrinker (MGPS) and the reporting odds ratio (ROR)
But they were never designed to correct every root cause of weight loss resistance on their own
